Journey Medical Corp

NASDAQ:DERM 4:00:00 PM EDT

3.86

+0.06 (+1.58%)

5:25:35 PM EDT: $3.90 +0.04 (+1.04%)

Market Cap (Intraday)	76.94M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$14.11 Million
Adjusted EPS	-$0.24

See more estimates

10-Day MA	$3.96
50-Day MA	$3.88
200-Day MA	$3.70

See more pivots

Journey Medical Corp Stock, NASDAQ:DERM

9237 E Via de Ventura Boulevard, Suite 105, Scottsdale, Arizona 85258

United States of America

Phone: +1.480.434.6670

Number of Employees: 58

http://www.journeymedicalcorp.com

Description

Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.